Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-scientist5.jpg" NAME"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free" ALT"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free"June 5, 2017By <A HREF"http://www.biospace.com/news…
Source: BioSpace